Cbdmd therapeutics announces human clinical study in collaboration with the university of south carolina

Charlotte, n.c.--(business wire)--cbdmd, inc. (nyse american: ycbd, ycbdpa) (the “company”), one of the leading, and most highly trusted and recognized cannabidiol (cbd) brands, announced today that it has commenced a preclinical human study with researchers at the university of south carolina. the study will explore the effects of cbdmd's proprietary broad spectrum cannabinoid blend on sleep, mood, and pain in healthy subjects to further support the efficacy of the company's products. the stud
YCBD Ratings Summary
YCBD Quant Ranking